
Urgent recall issued for popular ice cream brand for plastic contamination fears
Wells Enterprises has recalled 22 varieties of its three-gallon tubs of frozen desserts that went to 103 distribution centers across the US.
The company based in Le Mars, Iowa, initiated the voluntary recall on April 25. But the US Food and Drug Administration (FDA), which is a federal agency protecting public health across the nation, on May 14 upgraded the recall to Class II, which is the second-highest level for products.
Anywhere from 17 to more than 5,000 tubs of each item are under the recall. Wells Enterprises makes ice cream for popular brands including Blue Bunny and Glenview Farms.
Many of the affected items are vanilla flavored.
The item that is most impacted is Vanilla Frozen Yogurt, which has 5,280 tubs under the recall. It is followed by Glenview Farms Artificially Flavored French Vanilla Ice Cream with 2,261 tubs recalled, BIPC Flavored Ice Cream with 1,858 tubs recalled, Glenview Farms Vanilla Flavored Ice Cream with 1,573 tubs recalled, and Gordon Choice Vanilla Flavored Ice Cream with 1,080 tubs recalled.
There are also 961 tubs of Vanilla Flavored Ice Cream, 937 tubs of Planet Smoothie ZSA Vanilla Flavored Fat Free Frozen Yogurt, 726 tubs of Scooper Hero Ice Cream, 699 Ellington Farms Vanilla Flavored Ice Cream, and 569 tubs of Keith Valley Vanilla Flavored Ice Cream recalled.
In addition, there are 359 tubs of Mocha Almond Fudge Ice Cream, 320 tubs of Vanilla Bean Ice Cream with Madagascar vanilla, 280 tubs of Quick Blend Vanilla Flavored Ice Cream, 240 tubs of Country Rich Vanilla Ice Cream, and 201 tubs of Peanut Butter 'N Fudge Ice Cream recalled.
The items with a relatively fewer number recalled were Rocky Road Flavored Ice Cream with 169 tubs affected, GFGB Vanilla Bean Flavored Ice Cream with 120 tubs, GFGB 12% Vanilla Flavored Ice Cream with 109 tubs, Johnny Rockets Vanilla Flavored Ice Cream with 100 tubs, Glenview Farms Chocolate Ice Cream with 67 tubs, Cotton Candy Flavored Ice Cream with 39 tubs, and Artificially Flavored French Vanilla Ice Cream with 17 tubs.
They have best if used by dates from March to October 2026.
The FDA defines Class II as the product possibly being able to 'cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote'.
Le Mars was nicknamed the 'Ice Cream Capital of the World' in 1994 just because Wells Enterprises is headquartered there. Items under the recall were produced at the company's South Ice Cream Plant located in Le Mars.
The FDA classification came days after the supermarket chain Publix recalled pouches of baby food over fears of lead contamination.
Get in touch with our news team by emailing us at webnews@metro.co.uk.
For more stories like this, check our news page.
MORE: Urgent recall of macadamia nuts over E.coli contamination fears
MORE: Family 'find wrong man in loved one's casket wearing his suit'
MORE: Joe Biden's 'aggressive' cancer diagnosis: Type, treatments and prognosis
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
a day ago
- Reuters
Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH
Aug 15 (Reuters) - Novo Nordisk ( opens new tab said on Friday the U.S. Food and Drug Administration had granted accelerated approval for its weight-loss drug Wegovy to treat a serious liver condition known as metabolic dysfunction-associated steatohepatitis. The decision makes Wegovy the first GLP-1 class therapy cleared for MASH, a progressive liver condition that affects around 5% of adults in the U.S., according to the American Liver Foundation. The approval is for use alongside a reduced-calorie diet and increased physical activity. The FDA's approval was based on part 1 of a two-part study that showed Wegovy helped more patients with MASH and liver scarring improve the organ's condition, compared to a placebo. At 72 weeks, nearly 37% of patients on Wegovy saw an improvement in liver fibrosis, compared to 22.4% on placebo. Nearly 63% of those on Wegovy had their liver inflammation resolved, versus 34.3% for placebo. No worsening of the disease was seen in these patients. Accelerated approvals allow the agency to move therapies that target serious and life-threatening conditions to the market more quickly. However, such approvals have been criticized because some drugs have later been proven to be ineffective.


The Independent
a day ago
- The Independent
What to know about new flu vaccine nasal spray
Eligible adults in 34 states can now order the FluMist Home nasal spray flu vaccine online for the first time, allowing for at-home administration. Previously only available at pharmacies or doctors' offices, the vaccine can be ordered via providing a more convenient option for flu protection. FluMist Home is suitable for self-administration by individuals aged 18 to 49, and can also be given to children and teens aged two to 17. The nasal spray, approved by the FDA for at-home use last September, should be stored in a refrigerator and is typically free with insurance, though an $8.99 shipping and processing fee applies. This initiative aims to improve accessibility and convenience for flu vaccination, particularly following the worst flu season in 15 years and declining vaccination rates.


Reuters
a day ago
- Reuters
US FDA approves Tonix Pharma's drug to manage pain related to chronic condition
Aug 15 (Reuters) - The U.S. Food and Drug Administration has approved Tonix Pharmaceuticals' (TNXP.O), opens new tab drug to manage pain related to a type of chronic condition, the company said on Friday.